# Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers

> **NCT00183846** · PHASE1 · COMPLETED · sponsor: **University of Southern California** · enrollment: 22 (actual)

## Conditions studied

- Pancreatic Cancer
- Gastric Cancer
- Duodenum Cancer
- Bile Duct Cancer

## Interventions

- **DRUG:** irinotecan
- **PROCEDURE:** radiation therapy

## Key facts

- **NCT ID:** NCT00183846
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-12
- **Primary completion:** 2007-10
- **Final completion:** 2009-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2014-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00183846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00183846, "Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00183846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*